Otsuka Holdings
4578.T
#635
Rank
โ‚ฌ36.03 B
Marketcap
68,77ย โ‚ฌ
Share price
0.63%
Change (1 day)
49.37%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2026 (TTM): โ‚ฌ2.80 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚ฌ16.95 Billion. In 2025 the company made an earning of โ‚ฌ3.00 Billion, an increase over its 2024 earnings that were of โ‚ฌ2.06 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚ฌ2.80 B-6.51%
2025 โ‚ฌ3.00 B45.77%
2024 โ‚ฌ2.06 B117.32%
2023 โ‚ฌ0.94 B-20.93%
2022 โ‚ฌ1.19 B-12.7%
2021 โ‚ฌ1.37 B-19.92%
2020 โ‚ฌ1.71 B13.9%
2019 โ‚ฌ1.50 B52.07%
2018 โ‚ฌ0.99 B11.22%
2017 โ‚ฌ0.89 B-36.03%
2016 โ‚ฌ1.39 B31.15%
2015 โ‚ฌ1.06 B
2013 โ‚ฌ2.20 B33.52%
2012 โ‚ฌ1.64 B-4.65%
2011 โ‚ฌ1.73 B45.53%
2010 โ‚ฌ1.18 B